From the Department of Plastic Surgery, University of Texas Southwestern Medical Center; and the Dallas Plastic Surgery Institute.
Plast Reconstr Surg. 2020 Jan;145(1):58e-66e. doi: 10.1097/PRS.0000000000006346.
The practice of chemical peeling remains an important aspect of the nonsurgical techniques available to the aesthetic surgeon when approaching skin rejuvenation. Despite past predictions of their disappearance in favor of lasers, the overall use of chemical peels by plastic surgeons continues to grow. In the past two decades, the techniques available to the clinician have evolved in safety and efficacy based on the dermatologic investigations of various individuals, including Obagi, Hetter, and Stone. The versatility, clinical endpoint-directed predictability, and favorable risk profile of chemical peels proffered by these latest advancements affirm that this modality is essential to the practice of the plastic surgeon treating patients with rhytides and dyschromias. This review presents the current role of chemical peels in skin rejuvenation, emphasizing the significant clinical advancements and their modern day applications and practice.
化学焕肤仍然是美容外科医生在进行皮肤年轻化治疗时可采用的非手术技术的重要方面。尽管过去曾预测化学焕肤将被激光所取代，但整形外科医生对化学焕肤的总体使用量仍在持续增长。在过去的二十年中，基于各种个体的皮肤科研究，包括 Obagi、Hetter 和 Stone，临床医生可使用的技术在安全性和有效性方面都得到了发展。这些最新进展提供的化学焕肤的多功能性、针对临床终点的可预测性和良好的风险特征，证实了这种治疗方式对于治疗皱纹和色素沉着的整形外科医生来说是必不可少的。本文回顾了化学焕肤在皮肤年轻化中的当前作用，强调了其显著的临床进展及其现代应用和实践。
